Denna sida på svenska
Loading profile information...

Publications

Detection of DNA viruses in prostate cancer
Smelov V, Bzhalava D, Arroyo Mühr Ls, Eklund C, Komyakov B, Gorelov A, et al
Scientific reports 2016;6():25235-

Detection of DNA viruses in prostate cancer (vol 6, 25235, 2016)
Smelov V, Bzhalava D, Muhr Lsa, Eklund C, Komyakov B, Gorelov A, et al
SCIENTIFIC REPORTS 2016;:26267-

Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study
Smelov V, Gheit T, Sundström K, Ploner A, Mckay-chopin S, Eklund C, et al
PloS one 2016;11(5):e0156215-

Sourcing of the WHO human papillomavirus type 18 international standards for HPV antibody levels
Faust H, Eklund C, Sukvirach S, Ngamkham J, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016;78():89-92

Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples
Lagheden C, Eklund C, Kleppe Sn, Unger Er, Dillner J, Sundström K
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016;80():36-9

Does human papillomavirus-negative condylomata exist?
Arroyo Mühr Ls, Bzhalava D, Lagheden C, Eklund C, Johansson H, Forslund O, et al
Virology 2015;485():283-8

Human papillomavirus type 197 is commonly present in skin tumors
Arroyo Mühr Ls, Hultin E, Bzhalava D, Eklund C, Lagheden C, Ekström J, et al
International journal of cancer 2015;136(11):2546-55

International standardization and classification of human papillomavirus types
Bzhalava D, Eklund C, Dillner J
Virology 2015;476():341-4

Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial
Elfström Km, Smelov V, Johansson Al, Eklund C, Naucler P, Arnheim-dahlström L, et al
International journal of cancer 2015;136(2):350-9

Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial
Smelov V, Elfström Km, Johansson Al, Eklund C, Naucler P, Arnheim-dahlström L, et al
International journal of cancer 2015;136(5):1171-80

Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study
Eklund C, Forslund O, Wallin Kl, Dillner J
Journal of clinical microbiology 2014;52(2):449-59

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
Elfström Km, Smelov V, Johansson Al, Eklund C, Nauclér P, Arnheim-dahlström L, et al
BMJ (Clinical research ed.) 2014;348():g130-

Are human papillomavirus DNA prevalences providing high-flying estimates of infection? An international survey of HPV detection on environmental surfaces
Smelov V, Eklund C, Arroyo Mühr Ls, Hultin E, Dillner J
Sexually transmitted infections 2013;89(8):627-

Expressed prostate secretions in the study of human papillomavirus epidemiology in the male
Smelov V, Eklund C, Bzhalava D, Novikov A, Dillner J
PloS one 2013;8(6):e66630-

False-positive prostate cancer markers in a man with symptomatic urethral Chlamydia trachomatis infection
Smelov V, Novikov A, Brown Lj, Eklund C, Strokova L, Ouburg S, et al
International journal of STD & AIDS 2013;24(6):501-2

Next generation sequencing for human papillomavirus genotyping
Arroyo Ls, Smelov V, Bzhalava D, Eklund C, Hultin E, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;58(2):437-42

The Swedish Cervical Cytology Biobank: Sample Handling and Storage Process
Perskvist N, Norman I, Eklund C, Litton Je, Dillner J
BIOPRESERVATION AND BIOBANKING 2013;11(1):19-24

Unbiased approach for virus detection in skin lesions
Bzhalava D, Johansson H, Ekström J, Faust H, Möller B, Eklund C, et al
PloS one 2013;8(6):e65953-

International collaborative proficiency study of Human Papillomavirus type 16 serology
Eklund C, Unger Er, Nardelli-haefliger D, Zhou T, Dillner J
Vaccine 2012;30(2):294-9

The 2010 global proficiency study of human papillomavirus genotyping in vaccinology
Eklund C, Forslund O, Wallin Kl, Zhou T, Dillner J, Who Human Papillomavirus Laboratory Network
Journal of clinical microbiology 2012;50(7):2289-98

Genotyping of human papillomavirus in triaging of low-grade cervical cytology
Söderlund-strand A, Eklund C, Kemetli L, Grillner L, Törnberg S, Dillner J, et al
American journal of obstetrics and gynecology 2011;205(2):145.e1-6

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer
Arnheim Dahlström L, Andersson K, Luostarinen T, Thoresen S, Ögmundsdottír H, Tryggvadottír L, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(12):2541-50

Global proficiency study of human papillomavirus genotyping
Eklund C, Zhou T, Dillner J, Who Human Papillomavirus Laboratory Network
Journal of clinical microbiology 2010;48(11):4147-55

No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden
Lundstig A, Dejmek A, Eklund C, Filinic I, Dillner J
Anticancer research 2007;27(6B):4159-61

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids
Wang Zh, Kjellberg L, Abdalla H, Wiklund F, Eklund C, Knekt P, et al
The Journal of infectious diseases 2000;181(2):456-62

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children
Af Geijersstam V, Eklund C, Wang Z, Sapp M, Schiller Jt, Dillner J, et al
International journal of cancer 1999;80(4):489-93

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11
Luostarinen T, Af Geijersstam V, Bjorge T, Eklund C, Hakama M, Hakulinen T, et al
INTERNATIONAL JOURNAL OF CANCER 1999;80(6):818-22

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
Lenner P, Wiklund F, Emdin So, Arnerlöv C, Eklund C, Hallmans G, et al
British journal of cancer 1999;79(5-6):927-32

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989
Af Geijersstam V, Wang Z, Lewensohn-fuchs I, Eklund C, Schiller Jt, Forsgren M, et al
International journal of cancer 1998;76(3):341-4

Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas
Wikström A, Eklund C, Von Krogh G, Lidbrink P, Dillner J
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1997;105(11):884-8

Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions
Strickler Hd, Schiffman Mh, Eklund C, Glass Ag, Scott Dr, Sherman Me, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 1997;6(3):183-8

Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein
Kónya J, Eklund C, Af Geijersstam V, Yuan F, Stuber G, Dillner J
The Journal of general virology 1997;78 ( Pt 10)():2615-20

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies
Christensen Nd, Dillner J, Eklund C, Carter Jj, Wipf Gc, Reed Ca, et al
VIROLOGY 1996;223(1):174-84

Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer
Dillner J, Wiklund F, Lenner P, Eklund C, Frederiksson-shanazarian V, Schiller Jt, et al
International journal of cancer 1995;60(3):377-82

Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer
Dillner L, Zellbi A, Avall-lundqvist E, Heino P, Eklund C, Pettersson Ca, et al
Cancer detection and prevention 1995;19(5):381-93

Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma
Heino P, Eklund C, Fredriksson-shanazarian V, Goldman S, Schiller Jt, Dillner J
Journal of the National Cancer Institute 1995;87(6):437-40

A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles
Eklund C, Dillner J
Journal of virological methods 1995;53(1):11-23

Show all publications